008930.KS
Hanmi Science Co Ltd
Price:  
36,500.00 
KRW
Volume:  
283,461.00
Korea, Republic of | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

008930.KS WACC - Weighted Average Cost of Capital

The WACC of Hanmi Science Co Ltd (008930.KS) is 8.2%.

The Cost of Equity of Hanmi Science Co Ltd (008930.KS) is 8.50%.
The Cost of Debt of Hanmi Science Co Ltd (008930.KS) is 5.35%.

Range Selected
Cost of equity 7.40% - 9.60% 8.50%
Tax rate 11.10% - 12.10% 11.60%
Cost of debt 4.00% - 6.70% 5.35%
WACC 7.1% - 9.3% 8.2%
WACC

008930.KS WACC calculation

Category Low High
Long-term bond rate 3.1% 3.6%
Equity market risk premium 5.8% 6.8%
Adjusted beta 0.74 0.81
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.40% 9.60%
Tax rate 11.10% 12.10%
Debt/Equity ratio 0.09 0.09
Cost of debt 4.00% 6.70%
After-tax WACC 7.1% 9.3%
Selected WACC 8.2%

008930.KS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 008930.KS:

cost_of_equity (8.50%) = risk_free_rate (3.35%) + equity_risk_premium (6.30%) * adjusted_beta (0.74) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.